Antipneumococcal vaccine in adults: capvaxive validated by HAS | The doctor’s daily life | Specialties

For example,

Antipneumococcal vaccine adults: capvaxive validated:

It is a newcomer to antipneumococcal prevention in adults. Moreover, The vaccine at 21 Valences Capvaxive. For example, marketed by the MSD laboratory and authorized in adults in Europe since March 2025, can be used within the framework of national strategy in those over 65 and adults aged 18 to 64 years at risk, in the same way as Prevenar 20, announces the High Authority for Health (HAS) in a new opinion.

At the end of January 2025. Similarly, the HAS recommended protecting all adults from pneumococcus from 65 with the Single Dose Vaccine Prevenar 20 (Pfizer). In addition, Registered with the 2025 vaccine calendar. the recommendation is awaiting care by health insurance in ordinary law in those over 65, the vaccine not being reimbursed at 65 % so far that in adults at risk.

Capvaxive is less advanced in its regulatory antipneumococcal vaccine adults: capvaxive validated journey. This vaccine is not yet available. Validation by the Ministry of Health is a prerequisite for its reimbursement by health insurance. its registration in the vaccination calendar.

Studies to specify the strategy – Antipneumococcal vaccine adults: capvaxive validated

The VPC 21 can be administered concomitantly with the antigripping vaccine (different sites). For the moment, concomitant administration with other recommended vaccines in adults has not been studied. As with Prevenar 20. the HAS does not pronounce at this stage on the need for iterative vaccination after the single dose.

In its opinion. the HAS does not favor one of the two vaccines, even if Capvaxive seems better suited to the circulating serotypes affecting seniors. This vaccine contains 21 serotypes (including 11 in common with Prevenar and 10 exclusive to VPC 21).

“HAS will see the entire antipneumococcal strategy of the child. adults with the results of the current modeling and in particular the relevance of antipneumococcal vaccine adults: capvaxive validated a preferential recommendation of the VPC 21 vaccine and/or the interest of a sequential administration with the VPC 20 vaccine in targeted populations”lit-on.

Insofar as this vaccine is recent. the high authority insists on the importance of driving ” quickly “ More studies on these points but also on the effectiveness and impact of real life, long-term protection, administration security with other vaccines (COVVI-19, DTP, VRS, ZONA).

Further reading: What is the risk of contracting measles during summer trips? Here is the opinion of the expertsEven living under the same roof, men and women are not exposed to the same chemicalsCan we repair the nerves thanks to stem cells?“At school, at work, I have always been faced with derogatory remarks”Nine benzodiazepines of summary on the drug list | The daily life of the pharmacist.

Comments (0)
Add Comment